Skip to main content
ADHERIUM LIMITED logo

ADHERIUM LIMITED — Investor Relations & Filings

Ticker · ADR ISIN · AU000000ADR1 ASX Manufacturing
Open in API
Filings indexed 878 across all filing types
Latest filing 2017-09-03 Director's Dealing
Country AU Australia
Listing ASX ADR

About ADHERIUM LIMITED

https://www.adherium.com

Adherium Limited is a digital health company specializing in the development and commercialization of connected medical devices and software solutions for chronic respiratory management. The company's primary offering is the Hailie® platform, which consists of advanced sensors that attach to various inhaler medications to monitor usage and technique. These sensors transmit data via Bluetooth to a mobile application and a cloud-based portal, providing patients and healthcare providers with real-time insights into medication adherence and respiratory health trends. By facilitating remote patient monitoring and data-driven clinical decisions, Adherium aims to improve health outcomes for individuals living with asthma and chronic obstructive pulmonary disease (COPD). The platform is utilized by healthcare systems, pharmaceutical companies, and clinical research organizations to enhance patient engagement and optimize treatment efficacy.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice (escrow release) 3 pages 255.3KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details changes in a director's relevant interests in securities, including the number of shares held before and after the change, nature of the interest, and other related information. This matches the description of a Director's Dealing report, which involves reporting personal share transactions or changes in shareholdings by company directors. The document is not an announcement of a report, nor is it a full financial report or other type of filing. Therefore, the correct classification is Director's Dealing (DIRS).
2017-09-03 English
Change of Director's Interest Notice (escrow release) 4 pages 271.1KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details the securities held by a director before and after a change, including the nature of the change (release of ASX escrowed securities). The content focuses on the personal share transactions of a company director, which aligns with insider trading or director dealings disclosures. There is no financial performance data, earnings information, or management discussion. The document is a formal notification of a director's change in shareholding interests, fitting the definition of Director's Dealing filings.
2017-09-03 English
Adherium receives US FDA 510k clearance 2 pages 569.1KB
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Adherium has received U.S. FDA 510(k) clearance for a new Smartinhaler device. It describes the product, its features, and the company's business but does not contain any financial data, regulatory filings, or detailed financial reports. It is not an earnings release, annual report, or any other formal financial filing. It is an announcement related to product approval and company news. Such announcements typically fall under Regulatory Filings (RNS) as they are general regulatory announcements and do not fit into other specific categories.
2017-08-31 English
Appendix 3B - escrow release 14 pages 761.6KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, including classes of securities, number of securities issued, issue price, purpose of the issue, security holder approvals, quotation of securities on ASX, and compliance with ASX rules. It references ASX rules such as Rule 7.1 and 7.1A, and includes a quotation agreement section. The document is a formal announcement related to the issuance and quotation of additional securities by the company Adherium Limited. It does not contain financial statements, management discussion, or earnings data. It is not a report but an official announcement of a capital market transaction involving new share issues and related securities. Therefore, the document fits the category of 'Share Issue/Capital Change' (SHA). The document length is substantial (15,000 characters), indicating it is not a mere brief notice but a full announcement form. Hence, the classification is SHA with high confidence.
2017-08-29 English
Preliminary Final Report - Appendix 4E 11 pages 825.2KB
Annual Report Classification · 95% confidence The document is titled 'APPENDIX 4E PRELIMINARY FINAL REPORT FOR THE YEAR ENDED 30 JUNE 2017' and contains detailed financial statements including consolidated statements of profit or loss, financial position, changes in equity, and cash flows for a full fiscal year. It includes comparative figures for the previous period and detailed commentary on financial results, expenses, and business activities. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement. The presence of comprehensive financial data and analysis for a full fiscal year aligns with the characteristics of an Annual Report (10-K equivalent in the Australian context). Although it is labeled as an Appendix 4E, which is a preliminary final report under ASX listing rules, it serves the same purpose as an annual financial report. Therefore, the appropriate classification is Annual Report (10-K). FY 2017
2017-08-28 English
Investor Conference Call Presentation 19 pages 822.0KB
Annual Report Classification · 95% confidence The document is titled 'Adherium FY17 Full Year Results Investor Update' and contains detailed financial data for the fiscal year ending June 30, 2017, including revenue, gross profit, operating expenses, net loss, and cash position. It also includes operational reviews, cost analysis, strategic priorities, and forward-looking statements. The content is comprehensive and covers the full fiscal year, indicating it is a full annual financial report rather than a brief earnings release or a presentation. The document length is substantial (15,000 characters), and it contains substantive financial data and analysis, not just an announcement or summary. Therefore, it fits the definition of an Annual Report (10-K equivalent). FY 2017
2017-08-28 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.